TOMSK, RUSSIA / RankWire.AI / – Russian scientists have conducted testing on a novel bioactive coating aimed at enhancing the integration of titanium orthopaedic implants with bone tissue. This innovative material incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide synthesis. Laboratory experiments demonstrated a marked increase in the survival rate of human mesenchymal stem cells on coated surfaces compared to uncoated titanium. The team analyzed the coating’s structure, chemical makeup, mechanical features, and biological effects. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers produced the experimental coatings using reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen-to-argon gas ratio during the deposition process to observe how each mixture influenced the surface properties. The study tested five different conditions, ranging from pure nitrogen to pure argon. Subsequent measurements included coating thickness, surface morphology, hardness, wettability, and chemical composition. Additional laboratory tests assessed how living human cells responded to the modified titanium surfaces.
Results indicated that the argon content influenced several physical aspects of the coatings. Surfaces created in pure argon were denser and harder than those produced with pure nitrogen. As the proportion of argon increased, coating thickness also grew. Chemical analysis detected nitrogen-carbon and nitrogen-oxygen bonds on the surfaces modified with these gases. The team compared human mesenchymal stem cells grown on coated titanium against cells on uncoated titanium. Biological assessments focused on cell viability and markers related to bone-cell differentiation.
Cell survival improved on coated titanium surfaces, tests reveal
The experiments showed that cells had significantly higher survival rates on the coated surfaces than on uncoated titanium, according to the study. After seven days, coatings with increased nitrogen content also appeared to suppress activity in certain genes involved in early bone-cell differentiation. Nevertheless, the cells maintained their ability to form bone despite these early gene activity changes. All tests were conducted under controlled laboratory conditions using human mesenchymal stem cells; the study did not involve testing in patients or clinical implant performance evaluation.
The research was carried out by scientists from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from Saint Petersburg State University. The project was supported through Russia’s national science program. The researchers aimed to identify gas mixtures that could produce coatings with advantageous physical, chemical, and biological characteristics. Hydroxyapatite, due to its calcium phosphate composition resembling mineral components in human bone, is already used in implant coatings.
Current research remains at the laboratory testing phase
The scientists have proposed further testing beyond the initial seven-day cell viability assessments. Plans include analyzing stem cell responses over periods ranging from 10 to 28 days, as well as studying the dissolution rate of the coatings and nitric oxide release into surrounding tissues in vivo. These additional investigations were not part of the published laboratory results. The present study primarily focuses on the properties of coated titanium substrates and in vitro cellular responses, without involving clinical trials or testing on orthopedic patients.
The findings offer comprehensive laboratory data on how different ratios of nitrogen and argon influence calcium phosphate coatings on titanium. Variations in thickness, density, hardness, chemical bonding, and cellular response across different gas mixtures were documented. The research also confirmed that coated samples supported greater stem-cell survival than bare titanium under controlled experimental conditions. However, the research remains in the preclinical stage, and the results do not yet confirm safety or effectiveness in humans. Additional biological tests will be necessary to explore properties not covered in this initial study.